Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Amyloidosis
NCT01677286Phase 2Completed
- Sponsor
- Boston University
- Start
- Jul 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in amyloidosis, sponsored by Boston University. Started Jul 2012; status: completed.
02
Drugs
doxycycline
03
Conditions
amyloidosis
Beyond the preview
Go deeper on NCT01677286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01677286.